Earnings results for Sanara MedTech (NASDAQ:SMTI)
Sanara MedTech Inc. is expected* to report earnings on 08/16/2021 after market close. The report will be for the fiscal Quarter ending Jun 2021. The reported EPS for the same quarter last year was $-0.18.
Sanara MedTech last released its earnings data on May 17th, 2021. The reported ($0.17) earnings per share for the quarter. The company earned $5.01 million during the quarter. Sanara MedTech has generated ($0.76) earnings per share over the last year (($0.57) diluted earnings per share). Earnings for Sanara MedTech are expected to grow in the coming year, from ($0.61) to ($0.11) per share. Sanara MedTech has confirmed that its next quarterly earnings report will be published on Monday, August 16th, 2021.
Analyst Opinion on Sanara MedTech (NASDAQ:SMTI)
1 Wall Street analysts have issued ratings and price targets for Sanara MedTech in the last 12 months. Their average twelve-month price target is $45.00, predicting that the stock has a possible upside of 25.00%. The high price target for SMTI is $45.00 and the low price target for SMTI is $45.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”
Sanara MedTech has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $45.00, Sanara MedTech has a forecasted upside of 25.0% from its current price of $36.00. Sanara MedTech has only been the subject of 1 research reports in the past 90 days.
Dividend Strength: Sanara MedTech (NASDAQ:SMTI)
Sanara MedTech does not currently pay a dividend. Sanara MedTech does not have a long track record of dividend growth.
Insiders buying/selling: Sanara MedTech (NASDAQ:SMTI)
In the past three months, Sanara MedTech insiders have not sold or bought any company stock. 78.40% of the stock of Sanara MedTech is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 7.29% of the stock of Sanara MedTech is held by institutions.
Earnings and Valuation of Sanara MedTech (NASDAQ:SMTI
Earnings for Sanara MedTech are expected to grow in the coming year, from ($0.61) to ($0.11) per share. The P/E ratio of Sanara MedTech is -63.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Sanara MedTech is -63.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Sanara MedTech has a P/B Ratio of 38.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here